Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche beats estimates with strong 2015 sales

January 28, 2016 Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin

Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …
News

AZ’s Lynparza gets prostate cancer breakthrough status

January 28, 2016 Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer

AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …
News

Novartis braces for cuts after mixed 2015 performance

January 28, 2016 Sales and Marketing Novartis, financial results, revenue, sales

Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …
News

New biopharma heads for Merck in North America and China

January 27, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck

Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …
Appointment

FDA reviews Jardiance as cardiovascular diabetes treatment

January 27, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance

The FDA has accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for their diabetes drug Jardiance to be …
News

Alliance Pharmaceuticals appoints new head of international business

January 27, 2016 Medical Communications, Sales and Marketing Alliance Pharmaceuticals

Alliance Pharmaceuticals has appointed Karim Husny as head of international business- a role in which he will support all Alliance …
Appointment

NICE recommends six drugs in final guidance

January 27, 2016 Research and Development, Sales and Marketing NHS, NICE

NICE has published final recommendations approving drug treatments for ovarian cancer, prostate cancer, multiple myeloma, gastric cancer and idiopathic pulmonary …
News

Johnson & Johnson hit by fall in 2015 sales

January 27, 2016 Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales

Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …
News

NICE backs biosimilars with arthritis drug endorsements

January 27, 2016 Research and Development, Sales and Marketing DMARDs, NICE, biosimilars, rheumatoid arthritis

NICE has published updated final guidance recommending seven biological disease modifying drugs (DMARDs) for treatment of severe rheumatoid arthritis which …
News

Post-sanctions Iran attracts pharma investment

January 26, 2016 Manufacturing and Production, Sales and Marketing Gulf Co-operation Council, Iran, Isral, Saudi Arabia, United Arab Emirates, middle east

Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to …
Feature

Shire tries again with lifitegrast dry eye FDA application

January 25, 2016 Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye disease, lifitegrast

Shire has resubmitted its New Drug Application (NDA) to the US FDA for its rejected dry eye syndrome drug lifitegrast. …
News

New chief exec at MannKind

January 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …
Appointment

AbbVie VP joins UCB Pharma

January 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Pascale Richetta, UCB, UCB Pharma

Pascale Richetta will join the UCB as its new head of the bone therapy patient value unit as from February …
Appointment

Amgen earns first Japanese nod for PCSK9 inhibitor

January 25, 2016 Sales and Marketing Amgen, Astellas, Japan, PCSK9 inhibitor, Repatha, evolocumab, high cholesterol

The Japanese Ministry of Health, Labour and Welfare has approved Amgen’s cholesterol-lowering medication Repatha, in a joint venture between Amgen …
News

Big pharma and UK universities launch £40m innovation fund

January 25, 2016 Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026